Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fatal familial insomnia: preventive doxycycline treatment in at-risk individuals
2010-022233-28Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of doxycycline in Fatal familial insomnia (FFI), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Survival after 10 years. Started Mar 2012; status: completed.
02
Drugs
doxycycline
03
Conditions
Fatal familial insomnia (FFI)
Beyond the preview
Go deeper on 2010-022233-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022233-28.